Latest news for Santen Pharmaceutical (OTC:SNPHF) Stock

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

News

Intraday Update

Markets

Movers

Trading Ideas

ACHN

ADSW

AHPI

ARXRF

ASNB

BCOW

BTBIF

CBCFF

CBLI

CGEN

CSBTF

CTLT

DEAC

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

EVRG

FCPT

FTMNF

GCFFF

GJNSY

GLGDF

GVDNY

HBAYF

HTCMF

LAKE

LAND

LGDOF

LGDTF

LLIT

LYTS

Blackrock Muniholdings Investment Quality Fund

Blackrock Muniholdings New York Quality Fund

MITEY

Blackrock Muniyield Michigan Quality Fund

MMIRF

Blackrock Muniyield Pennsylvania Quality Fund

MRNTF

Blackrock Muniholdings California Quality Fund

Blackrock Muniyield New York Quality Fund

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NVRO

Nuveen New Jersey Dividend Advantage Municipal Fund

OCPNY

OPYGY

PCYO

PLHCF

POYYF

QIFTF

QMCO

QTRHF

RWNFF

SNPHF

SPFI

TGLVY

TPRFF

VCNX

WFCF

WOSSF

XPPLF

MZEIQ

ALTKF

PHYS

NNVC

PSTO

FPWM

Stocks That Hit 52-Week Highs On Monday

SANTEN PHARM CO by Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has announced the repurchase of 2,855,300 of its common ...

Santen Pharmaceutical Reports Share Buyback Progress

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has completed a buyback of 2,857,200 common shares for a...

Santen Pharmaceutical Advances Share Buyback Program

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has resolved to dispose of 30,715 treasury shares on Sep...

Santen Pharmaceutical Rewards Leadership with Stock Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 30,715 treasu...

Santen Pharma Completes Key Stock Remuneration Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has announced the buyback of 1,348,400 of its common sha...

Santen Pharmaceutical Executes Share Buyback

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. has successfully repurchased over 2.2 million of its common sh...

Santen's Share Buyback Progress Update

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. has announced the cancellation of 16,985,400 treasury shares, ...

Santen Pharmaceutical Cancels Significant Treasury Shares

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. reported a slight revenue increase of 0.4% for the six months ...

Santen Pharmaceutical Co. Reports Mixed Financial Results

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. has announced plans to repurchase up to 5 million of its own s...

Santen Pharmaceutical Announces Share Buyback Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. has completed a share buyback, repurchasing 598,000 common sha...

Comments

Santen Pharmaceutical

News

Latest news for Santen Pharmaceutical (OTC:SNPHF) Stock

Monday, January 27, 2020

Friday, January 23, 2015

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga